Schedule 13G ownership disclosure

CELLECTAR BIOSCIENCES INC

Common Stock · CUSIP: 15117F807

Event date: 2024-12-31

Filing-level shares
3,955,470.00
Percent of class
8.8%
  • LYTTON LAURENCE W

    Shares: 3,955,470.00 · Class: 8.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-25-000144
Form type
SCHEDULE 13G/A
Filer
Cellectar Biosciences, Inc.
CIK
CIK 1279704
Filed
Feb 13, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub